Navigation Links
Neurocrine Announces Full Year Results from 603 Study (Petal Study) of Elagolix for Treatment of Endometriosis Pain
Date:5/18/2009

es across all domains "sometimes," "often" or "always." After treatment this shifted dramatically such that 60-80% of subjects said "never" or "rarely" to these same EHP-5 questions. Equally notable is the observation that much of this improvement was sustained post-treatment.

Estradiol and Ovulation: The previously reported pharmacodynamic effect of elagolix was confirmed. Median estradiol values were maintained in the low baseline range while on treatment and, most importantly, were not lowered to values that would be associated with hot flashes or clinically significant bone loss. As reported, Week 24 median estradiol was 47 pg/ml for elagolix once daily and 29 pg/ml for elagolix twice daily. At Week 48, the median values for the groups were normal at 80 pg/ml and 84 pg/ml, respectively. The mean time to ovulation post-treatment was 24 days for women who had been randomized to elagolix and >90% of subjects had evidence of ovulation within 4 weeks of stopping. Prolonged suppression of ovulation was documented, even out to Week 48 in the DMPA subjects who also reported frequent spotting and irregular vaginal bleeding.

Safety and Tolerability: Assessment of vital signs, physical examination, electrocardiogram, and clinical laboratory tests did not reveal any safety concerns. Adverse events that were reported were generally mild and transient in nature and not usually associated with study discontinuation. The most common adverse events in this trial were consistent with what we have observed in the other elagolix trials including headache (approximately 20% of subjects reported 1 or more headaches during the 6 months of treatment) and nausea (approximately 15% of subjects reported 1 or more episode of nausea). The most common reason for premature discontinuation from the study was withdrawal of consent (i.e., subject moved, work conflict, etc). Seven subjects withdrew from the study with excessive, prolonged or bre
'/>"/>

SOURCE Neurocrine Biosciences, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Neurocrine Biosciences Announces Conference Call and Webcast to Present First Quarter 2009 Financial Results
2. Neurocrine Biosciences Reports Fourth Quarter and Year-End 2008 Results
3. Webcast Alert: Neurocrine Announces 1Q08 Financial Results
4. Neurocrine Announces Closing of $109 Million Sale and Leaseback Agreement for its Real Estate Assets
5. Neurocrine Biosciences to Present at the CIBC World Markets 18th Annual Healthcare Conference
6. Coalition for Pulmonary Fibrosis Announces Awards and Activities at ATS International Conference
7. GNAX/AtlantaNAP Announces Newest Client, Health Information Designs
8. AstraZeneca Announces TOPROL-XL(R) (Metoprolol Succinate) is Now Available
9. AMR Research Announces Final Agenda for Sold-Out Supply Chain Executive Conference
10. International Student Insurance Announces Website Redesign
11. Light Sciences Oncology Announces Results of Study on Immunotherapeutic Mechanism of Aptocine(TM), a Novel Light-Activated Drug Therapy for Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... 2015 On Monday, June 1, KORT, ... 160 Frankfort Road in Shelbyville, Kentucky . Clinic Director, Chad ... well as treat patients , “ Shelbyville is a ... , local clinic to better serve the residents of Shelby ... experience as trouble-free as possible by providing accessible and immediate ...
(Date:5/28/2015)... Today the National Resident Matching Program ... 2015 Main Residency Match®. A record-number 30,212 positions ... when the matching algorithm was processed. Of the ... Match Week Supplemental Offer and Acceptance Program® (SOAP®) leading ... with the outcome of the 2015 Main Residency Match. ...
(Date:5/28/2015)... 28, 2015 Technology public relations ... (CNCK) as its agency of record to support ... app, SugarChecked. SugarChecked is an everyday grocery-shopping tool ... potential sugars they are putting in their bodies. ... of SugarChecked, execute media initiatives following launch, lead ...
(Date:5/28/2015)... Park Cities Pet Sitter is offering a 5-week “Training ... Saturday, June 6th at 10:30am. The classes will be ... Dallas, with a maximum of six dogs allowed in the ... no class being held over the 4th of July weekend. ... Intermediate-to-Advanced level class, dogs will solidify their practical behavior skills, ...
(Date:5/28/2015)... May 28, 2015 Dr. Jenyons’ ... an exclusive deal to patients looking to undergo its ... through 30, patients will be able to get a ... for just $600. For a three-treatment package, which costs ... at no cost. , Dr. Juanita Jenyons, M.D., says ...
Breaking Medicine News(10 mins):Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 2Health News:KORT Physical Therapy Opens New Clinic In Shelbyville, Kentucky 3Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 2Health News:NRMP Releases Results and Data: 2015 Residency Match: Record Number of Positions Filled 3Health News:ContentChecked Selects PMBC Group To Launch New Nutrition App SugarChecked 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 2Health News:Dallas-based Park Cities Pet Sitter to Offer “Training and Enrichment 2” Group Dog Training Class Beginning Saturday, June 6th, 2015. 3Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 2Health News:Dr. Jenyons’ Medical Weight Loss & Rejuvenation Center Now Offering Skin Treatment Specials 3
... SCOTTSDALE, Ariz., July 9 Four out of 10 adults who ... of children who stutter have been bullied or teased, according to ... make up about 1 percent of the population. , ... national conference in Scottsdale, AZ. , , While there ...
... D. Smith recently announced the promotions of Jeff Greer to ... vice president of purchasing and trade relations. These appointments ... senior leadership to maximize growth potential. , ... Company,s sales efforts to expand into new service sectors. ...
... ongoing recession and associated job cuts is creating a ... slowing health insurer growth and pressuring profitability, according to ... , "Conning projects that health care costs will ... margins through 2011," said Terence Martin, analyst at Conning ...
... 2009 As soccer continues to grow in popularity, injuries ... Certain injuries fall into gender-based patterns and new ... causes that could help lead to better treatment, or ... Data presented at this year,s American Orthopaedic Society for ...
... MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today announced ... license agreement with AstraZeneca related to the company,s Unit Dose ... July 8, 2009, effective immediately. All rights licensed to ... MAP Pharmaceuticals plans to suspend development of UDB, which did ...
... and HAMILTON, New Zealand, July 9 ZyGEM Corp. ... extraction and other life sciences applications, today announced the ... prep GEM(R) Bacteria DNA extraction kit is capable ... range of bacterial species, including mixed or unknown sample ...
Cached Medicine News:Health News:Survey: Speech Therapy Helps, But People Who Stutter Suffer Discrimination 2Health News:H. D. Smith Promotes Leadership to Fill Two Senior Roles 2Health News:Conning Research: Health Insurance Industry Premium Growth and Profitability Under Pressure Through 2011 2Health News:Motion analysis helps soccer players get their kicks 2Health News:Motion analysis helps soccer players get their kicks 3Health News:MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 2Health News:MAP Pharmaceuticals Announces Termination of Pediatric Asthma Collaboration 3Health News:ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species 2Health News:ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species 3Health News:ZyGEM Releases Data Confirming Its prepGEM(R) Bacteria Kit Is a Simple, Universal Method for Extracting DNA from Different Bacteria Species 4
(Date:5/28/2015)... 28, 2015   Mast Therapeutics, Inc. ... its molecular adhesion and sealant technology (MAST) platform ... heart failure, and arterial disease, today announced that ... Board of Directors. Mr. Lief made this decision ... his role as President and Chief Executive Officer ...
(Date:5/28/2015)... and DEKALB, Ill. , ... a Letter of Intent to explore an affiliation ... several months, KishHealth and NMHC will further define ... and approval. "KishHealth is recognized for ... excellence," said Dean M. Harrison , President ...
(Date:5/28/2015)... May 28, 2015 ... the addition of Jain PharmaBiotech,s new report  ...  to their offering.  ,     (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , ... treatment is to match the right drug ... cases, even to design the appropriate treatment ...
Breaking Medicine Technology:Mast Therapeutics Announces Change In Board Of Directors 2Mast Therapeutics Announces Change In Board Of Directors 3Mast Therapeutics Announces Change In Board Of Directors 4KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 2KishHealth System Explores Affiliation with Northwestern Memorial HealthCare 3Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 2Global Personalized Medicine Report 2015-2024 - Scientific and Commercial Aspects 3
... 2012  Mundipharma International has appointed Paul Medeiros to ... this position, Mr. Medeiros will join the Executive ... extending and expanding avenues for corporate growth within ... are growing faster than any other midsized pharmaceutical ...
... BIOR, OTCQB: BIOR), producer of the FDA cleared STREAMWAY ... it has appointed Joshua Kornberg to the Company,s Board ... Officer of BioDrain, commented, "We are thrilled to bring ... healthcare and biotechnology fund dedicated to bridge financing of ...
Cached Medicine Technology:Mundipharma's Commitment to Accelerated Business Growth Supported by Appointment of Paul Medeiros to Head Its Corporate and Business Development 2BioDrain Medical Inc. Appoints New Board Member 2BioDrain Medical Inc. Appoints New Board Member 3
... With the increase in Endoscopic cases it ... LCD Monitor with the Surgical Light. This ... monitor without having to adopt an uncomfortable pose. ... of including the NUVO Monitoring System. As ...
... clearly the favorite for most surgical procedures. ... dual light heads rotate freely about the ... positioning. Engineered construction prevents any conflict between ... invasive through trauma to cardiovascular the dual ...
... procedural specialty, whether it be Endoscopic, ... System will complement the procedure through ... advanced high-resolution display technology. Unlike monitors ... the NUVO Monitor provides unrestricted positioning ...
The anti-MAG autoantibodies EIA employs the quantitative enzymatically amplified sandwich-type immunoassay technique. HIGHLY PURIFIED MAG FROM HUMAN BRAIN has been precoated onto a microtiter plate....
Medicine Products: